Fiber-Modified Adenovirus for Central Nervous System Parkinson’s Disease Gene Therapy

Gene-based therapies for neurological diseases continue to develop briskly. As disease mechanisms are elucidated, flexible gene delivery platforms incorporating transcriptional regulatory elements, therapeutic genes and targeted delivery are required for the safety and efficacy of these approaches....

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Travis B., Glasgow, Joel N., Harms, Ashley S., Standaert, David G., Curiel, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147696/
https://www.ncbi.nlm.nih.gov/pubmed/25196484
http://dx.doi.org/10.3390/v6083293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147696/
https://www.ncbi.nlm.nih.gov/pubmed/25196484
http://dx.doi.org/10.3390/v6083293

Ejemplares similares